Yan Daiming academician workstation settled in Yan'an to carry out digestive tract tumor screening.

(Health Times reporter Ye Zhengxing) Recently, in order to support the medical development of the old district of Yan'an, by the Chinese Academy of Engineering Vice President Yu Daiming, the Communist Party of China Yan'an Municipal Committee, Yan'an Municipal People's Government, the Fourth Military Medical University Xijing Digestive Hospital, the National Digestive System Disease Clinical Medical Research Center and Yan'an University Affiliated Hospital jointly organized the Yan'an University Affiliated Hospital "Academic Workstation" and gastrointestinal tumor public welfare screening project officially launched in Yan'an, Shaanxi Province.
is understood that the Fourth Military Medical University Xijing Digestive Hospital is currently the world's largest hospital for digestive diseases, ranking first in the country's best professional reputation list for 6 consecutive years, with the National Key Laboratory of Oncology Biology and the National Center for Clinical Medicine of Digestive Diseases, and the academician is the director of the laboratory and center.the academician Yu Daiming to make a keynote speech on the spot
" teacher is a special industry, with long sitting at work, less activity, irregular diet characteristics, these factors are digestive tract tumors, especially colorectal cancer incidence of important induced conditions. The first thing the academician's workstation was located at Yan'an University Hospital was to conduct a public screening of gastrointestinal tumors for teachers.
this public welfare screening project, selected The University of Yan'an Revolutionary Old District, middle school teachers as screening object, plans to cover 2000 people, the use of the most advanced gastrointestinal tumor detection technology in the world to screen teachers. According to reports, the public welfare screening, the use of the current only by the United States FDA, China CFDA and the European Union CE approval can be applied to the clinical non-invasive early colorectal cancer blood testing product Septin9 gene methylation testing technology, the early detection rate of colorectal cancer is higher than the existing technology 4 to 5 times.
as a research station landing unit, Yan'an University Hospital President Professor Bruce Lee said that the digestive system tumor in Yan'an area high incidence, and the local situation is very suitable, the future will be digestive medicine, hepatobiliary surgery, general surgery, oncology, imaging diagnosis, test diagnosis, pathology, etc. integrated in the academician workstation, reduce the incidence of gastrointestinal tumors in the region.Professor Wu Kaichun, executive vice president of Xijing Digestive Hospital of the Fourth Military Medical University of
, said that through the screening campaign, he hoped to understand the gastrointestinal tumors and precancerous lesions of teachers in Yan'an district and raise the awareness of Yan'an citizens on cancer prevention.
.